JPRN-jRCT2080221250未知3 期
DD-723 Phase III Clinical Trial - Confirmatory Study in Subjects with Breast Tumor
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 120 人开始时间: 2010年9月27日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects with focal breast tumors
- •- Subjects scheduled to undergo pathological examination
- •- Subjects aged >=20 years old at the time of informed consent
排除标准
- •- Items listed on the package insert (including absolute contraindications, careful administration, and precautions) to ensure safety
- •- Items related to safety and ethics
- •- Items related to surgery, procedures, and treatment influencing efficacy and safety assessment for DD-723
- •- Subjects who are pregnant, possibly pregnant, or lactating
研究者
相似试验
未知
3 期
DD-723 Phase III Clinical Trial (Prostate)Subjects with suspected prostate cancerJPRN-jRCT2080221271DAIICHISANKYO Co.,Ltd.120
未知
2 期
DD-723 Phase II clinical trial (Breast)Patients with breast tumorJPRN-jRCT2080220863DAIICHISANKYO Co.,Ltd.75
未知
1 期
Phase I Clinical Trial of DS-7423JPRN-jRCT2080221724DAIICHISANKYO Co.,Ltd.27
未知
2 期
DD-723 Phase II clinical trial (Prostate)Patients with suspected prostate cancerJPRN-jRCT2080220862DAIICHISANKYO Co.,Ltd.75
未知
3 期
Phase 3 Clinical Trial with MD-0901JPRN-jRCT2080222425MOCHIDA PHARMACEUTICAL CO., LTD.250